Related Experiment Video
Updated: Mar 1, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.5K
Pancreatic Squamous Cell Carcinoma.
Seyed Hassan Abedi1, Alireza Ahmadzadeh1,2, Amir Houshang Mohammad Alizadeh1
1Shahid Beheshti University of Medical Sciences, Taleghani Hospital, Tehran, Iran.
Case Reports in Gastroenterology
|June 1, 2017
Summary
Pancreatic squamous cell carcinoma (SCC) is a rare and aggressive cancer. This case report details a 56-year-old man diagnosed with advanced pancreatic SCC, highlighting its challenging nature.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Pancreatic squamous cell carcinoma (SCC) is an exceptionally rare subtype of pancreatic cancer.
- It is characterized by aggressive behavior and poor response to conventional treatments.
Observation:
- A 56-year-old male presented with a hypodense pancreatic mass and regional lymphadenopathy.
- Imaging revealed encasement of major visceral arteries and veins by the pancreatic mass.
- Endoscopic ultrasound identified a 45x37 mm mixed-echogenicity mass in the pancreatic trunk.
Findings:
- Histological examination of fine needle aspiration confirmed squamous cell carcinoma.
- The disease was locally advanced at diagnosis, indicating a poor prognosis.
- Pancreatic SCC demonstrates high aggressiveness and limited treatment responsiveness.
Implications:
- This case underscores the diagnostic challenges and aggressive nature of pancreatic SCC.
- Early detection and novel therapeutic strategies are crucial for improving outcomes.
- Further research into pancreatic SCC pathogenesis and treatment is warranted.
